SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RKDA, CKPT, QTRX on Behalf of Shareholders

22.04.25 22:33 Uhr

Werte in diesem Artikel

NEW YORK, April 22, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

Halper Sadeh LLC (PRNewsfoto/Halper Sadeh LLP)

Arcadia Biosciences, Inc. (NASDAQ: RKDA)'s merger with Roosevelt Resources LP. Upon closing of the proposed transaction, Arcadia shareholders are expected to own approximately 10% of the combined company. If you are an Arcadia shareholder, click here to learn more about your rights and options.

Checkpoint Therapeutics, Inc. (NASDAQ: CKPT)'s sale to Sun Pharmaceutical Industries Limited for $4.10 per share and a contingent value right for up to $0.70 per share on achievement of a milestone. If you are a Checkpoint shareholder, click here to learn more about your rights and options.

Quanterix Corporation (NASDAQ: QTRX)'s merger with Akoya Biosciences, Inc. Upon completion of the proposed transaction, Quanterix shareholders will own approximately 70% of the combined company. If you are a Quanterix shareholder, click here to learn more about your rights and options.

Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders. We would handle the action on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-investigation-halper-sadeh-llc-investigates-rkda-ckpt-qtrx-on-behalf-of-shareholders-302435007.html

SOURCE Halper Sadeh LLP

In eigener Sache

Übrigens: Checkpoint Therapeutics und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf Arcadia Biosciences

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Arcadia Biosciences

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Nachrichten zu Checkpoint Therapeutics

Wer­bung